Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease ( nginin Candida infections caused by no...)

Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease

ngin in Candida infections caused by non-albicans Candida species in phase III trials. ECCMID, Munich. Abstract number (tbd).

(9) Ullmann AJ et al. Efficacy of micafungin in patients with deep, invasive Candida infections. ECCMID, Munich. Abstract number (tbd).

(10) Ullmann AJ et al. A review of the safety of micafungin compared with liposomal amphotericin B in a large, phase III trial in patients with invasive candidiasis and candidaemia. ECCMID, Munich. Abstract number (tbd).

(11) Arrieta A et al. Micafungin versus liposomal amphotericin B (AmBisome(R)) in paediatric patients with invasive candidiasis or candidaemia. ECCMID, Munich. Abstract number (tbd).

CONTACT: Astellas Pharma Ltd, Lovett House, Lovett Road, Staines, TW183AZ, Tel: +44(0)1784-419615

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Page: 1 2 3 4 5
Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
5. Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study
6. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
9. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
10. Alzheimers Drug Shows Promise in Fighting Cancer
11. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer

Post Your Comments:

(Date:10/13/2008)...r NIH funding advances study Study needed be...APOLIS, Oct. 13 /- Advanced Circulato...com ) announced today that it has received,an addi...nstitutes of,Health (NIH) to continue a study test...xperience cardiac arrest outside a hospital. Whatc...

(Date:10/13/2008)... Have Higher Sensitivity and Specificity, than Ot... the preferred test in all phases ... /- AT First Diagnostic LLC an,emergi...test kits, today,announced that a recent evaluatio...esearch of the FirstVue(TM) HBSAG Test, was releas...

(Date:10/12/2008)...d in Combination with Chemotherapy, FREMONT, Cali...Inc., a,development-stage pharmaceutical company d...RNAi)-based therapeutics, today announced that the...cacy of siRNA targeting,its proprietary target gen...e edition dated October 1, 2008. The paper, entitl...

(Date:10/10/2008)...- Diplomat Specialty,Pharmacy announc...mat,Specialty Pharmacy to be one of only three sit...py Optimization Study for Multiple Sclerosis (TOP ...to examine the benefits of a,specialty pharmacy th...and,patient outcomes. Targeted patient outcomes wi...

Breaking Medicine Technology:Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2 Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2 Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3 Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4 Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2 Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference 2438 1 Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference 2438 2 Danaher to Present at J P Morgan Healthcare Conference 2435 1 Lack of Deep Sleep Raises Diabetes Risk 9038 1 Lack of Deep Sleep Raises Diabetes Risk 9038 2 Lack of Deep Sleep Raises Diabetes Risk 9038 3 FDA approves additional dosage strengths of Vyvanse 9035 1 FDA approves additional dosage strengths of Vyvanse 9035 2

[0] Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques [1] Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests [0] Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy [0] Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS)

...olecularly engineered,therapy selectively embeds a...tes tumors, inhibits metastasis, and prolongs surv...The University of,Texas M. D. Anderson Cancer Cent..."This vehicle, or vector, is so targeted and robus... used for therapy and,perhaps for imaging," notes ...

...ospinol,s (SP-233) Ability to Clear Brain,Plaque a...ion , In Vivo ,Proof of Concept, Study Proposes Di...que and Memory Recovery , LAS VEGAS, July 10, 2007.... (AMEX:LIV), a developer of innovative drugs,is ... (SP-233),efficacy in its ability to dramatically ...

Other Medicine Technology:Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 2 Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 3 Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 4 Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell 5 Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 2 Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 3

Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial,Targeting System's Success in Mouse Model Reported in Cancer Cell Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease

(Date:10/15/2008)... Will Educate Parents about Prescription,Drug Abus...mily Partnership (NFP),has designated Monday, Octo...g off the group,s 23rd annual Red Ribbon Week from...ents with action steps to prevent children,s,presc...million teens in the United States abuse,prescript...

(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Kerby T.,Alvy, Ph.D.,...r for the,Improvement in North Hollywood (CICC), h... and Prevention (CDC) to serve as an expert to inf...or the prevention of child,maltreatment., CDC,s n...lationships,(SSNR) as the foundation for a unified...

(Date:10/14/2008)...ker Founder and CEO Andrew Levitt to showcase Heal... Somerville, MA (PRWEB) Octob... , the word-of-mouth marketing (WOM) firm for the ... announced that Andrew Levitt, Founder and CEO of ...Pharma and Health 2.0" at Health 2.0: User-Ge...

(Date:10/14/2008)...PRNewswire-FirstCall/ -- Warner Chilcott,Limited (... its third quarter,2008 financial results prior to... In addition to issuing a press release, the Comp... parties on Monday, November 10, 2008 at,8:00 AM (...e in the call,please dial (877) 856-1955 in the U...

Breaking Medicine News(10 mins):Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2 Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3 Health News:Los Angeles Psychologist to Help CDC Fight Child Abuse 2 Health News:HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 2

[0] National Family Partnership Designates October 27th 'Lock Your Meds' Day [0] Los Angeles Psychologist to Help CDC Fight Child Abuse [0] HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' [0] Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results

...i bacteria outbreak in some vegetables revealed th...ffective in treating deadly //bacteria’s, growing ...have come up with an alternate solution - Edible c...eria apart from adding flavor. Edible coating for...

...e, one of the main ingredients in tooth whitening ...nd is safe to use–says an article //written by Dr....ased Tooth Whitening Products and it Relationship ...hed in Journal of Esthetic and Restorative Dentist...

...reat kidney cancer can prevent the development of ... lungs) in rodents, report researchers //from the ...f the American Heart Association, Nov. 12-15 in Ch...r this condition. 'We are excited about this fin...

...f migration season this winter, officials fear tha...irus H5N1 in Egypt and in other parts of the world...the necessary precautions well in advance on accou... flu virus might be even more deadly among fowl an...

Other Medicine News:Health News:Edible Food Coating Kills Bacteria And Adds Flavor 2 Health News:Edible Food Coating Kills Bacteria And Adds Flavor 3 Health News:Anti-Cancer Drug Shows Early Promise in Pulmonary Hypertension 2

Edible Food Coating Kills Bacteria And Adds Flavor Tooth Whitening Products Do Not Cause Oral Cancer Anti-Cancer Drug Shows Early Promise in Pulmonary Hypertension Bird Flu Danger Renewed With The Onset Of Migration Season

Sabre 180, 230V, 50Hz is a powerful niche generator.

Microcontroller-based isolated electrosurgical generator, designed for all general purpose surgical procedures. Unit includes: Instant Response technology, adaptive REM system, isolated output, CEM c

Maddox rod and occluder

Long handle occluder - White

Medicine Products:

Sabre 180 Force FX Electrosurgical Generator Maddox Rod and Occluder Long Handle Occluder - Black

( nginin Candida infections caused by no...)Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease,Health